or Try an Advanced Search...

    Technical Analysis for PAR - Paradigm Biopharmaceuticals Ltd

    Grade Last Price % Change Price Change
    F 0.277 8.63% 0.022
    PAR closed down 5.56 percent on Monday, April 29, 2024, on 2.43 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical PAR trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish 8.63%
    Expansion Breakdown Bearish Swing Setup 8.63%
    New 52 Week Low Weakness 8.63%
    Wide Bands Range Expansion 8.63%
    Gapped Up Strength 8.63%
    Oversold Stochastic Weakness 8.63%
    New 52 Week Closing Low Bearish 2.59%
    Stochastic Reached Oversold Weakness 2.59%
    Wide Bands Range Expansion 2.59%
    Oversold Stochastic Weakness 2.59%
    Older End-of-Day Signals for PAR ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 2 hours ago
    Up 10% about 4 hours ago
    10 DMA Resistance about 4 hours ago
    3x Volume Pace about 4 hours ago
    Gap Up Partially Closed about 5 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    PAR Chart by TradingView
    Basic chart:

    Profile

    Paradigm Biopharmaceuticals Limited is a biopharmaceutical company focused on repurposing the drug pentosan polysulfate sodium (PPS) for the treatment of inflammation. The Company is engaged in researching and developing therapeutic products for human use. The Company is a drug repurposing company, which seeks to find new uses for old drugs. The Company has commenced the open labelled Phase II clinical trial, investigating the role of the drug PPS in treating traumatic Bone Marrow Lesions. The Company's Rhinosul has properties consisting of both histamine stabilizing and anti-inflammatory properties. The Company focuses on repurposing PPS under ZILOSUL name, as a treatment for bone marrow edema (BME) lesions following traumatic injury.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pharmaceutical Drugs Pharmaceuticals Clinical Trial Biopharmaceutical Medical Specialties Pharmaceutical Industry Therapeutic Product Therapeutic Products Medication Organ Systems Inflammation Osteochondritis Dissecans

    Is PAR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.115
    52 Week Low 0.25
    Average Volume 605,782
    200-Day Moving Average 0.519
    50-Day Moving Average 0.341
    20-Day Moving Average 0.302
    10-Day Moving Average 0.282
    Average True Range 0.022
    RSI (14) 27.54
    ADX 27.05
    +DI 11.670
    -DI 28.278
    Chandelier Exit (Long, 3 ATRs) 0.293
    Chandelier Exit (Short, 3 ATRs) 0.317
    Upper Bollinger Bands 0.356
    Lower Bollinger Band 0.248
    Percent B (%b) 0.07
    BandWidth 35.918
    MACD Line -0.022
    MACD Signal Line -0.020
    MACD Histogram -0.0019
    Fundamentals Value
    Market Cap 58.15 Million
    Num Shares 228 Million
    EPS -0.11
    Price-to-Earnings (P/E) Ratio -2.34
    Price-to-Sales 0.00
    Price-to-Book 6.20
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.315
    Resistance 3 (R3) 0.320 0.305 0.305
    Resistance 2 (R2) 0.305 0.290 0.303 0.302
    Resistance 1 (R1) 0.280 0.280 0.273 0.275 0.298
    Pivot Point 0.265 0.265 0.261 0.263 0.265
    Support 1 (S1) 0.240 0.250 0.233 0.235 0.212
    Support 2 (S2) 0.225 0.240 0.223 0.208
    Support 3 (S3) 0.200 0.225 0.205
    Support 4 (S4) 0.195